ZOLADEX

Implant in pre-filled syringe, 3.6mg
RxActive license

Active substance (INN)

goserelin

Pharmaceutical form

Pharmaceutical formImplant in pre-filled syringe
Strength3.6mg
PackagingUkupno 1 napunjeni injekcioni špric sa 3.6mg implanta u kartonskoj kutiji
ManufacturerAstraZeneca UK Limited, United Kingdom
Therapeutic groupAntineoplastic and immunomodulating agents (L02AE03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateFebruary 20, 2026

Analogs in Montenegro

3

Other medicines with the same active substance

RESELIGORestricted
Implant in pre-filled syringe, 3.6mgAMW GmbH
RESELIGORestricted
Implant in pre-filled syringe, 10.8mgAMW GmbH
ZOLADEX LARx
Implant in pre-filled syringe, 10.8mgAstraZeneca UK Limited
Source: CInMED register